Global Molecular Imaging Procedures Growth Opportunities

Global Molecular Imaging Procedures Growth Opportunities

The Development of Novel Radiopharmaceuticals and the Expanding Clinical Applications for Molecular Imaging Equipment will Create Opportunities for the Growth of Procedures

RELEASE DATE
22-Feb-2022
REGION
North America
Deliverable Type
Market Research
Research Code: PCB3-01-00-00-00
SKU: HC03510-NA-MT_26299
AvailableYesPDF Download
$2,450.00
In stock
SKU
HC03510-NA-MT_26299
$2,450.00
DownloadLink
ENQUIRE NOW

Description

This Frost & Sullivan research service presents an analysis of the global molecular imaging (MI) procedures market and an overview of the development of novel radiopharmaceuticals. It offers an in-depth analysis of current trends and a forecast for PET/CT and SPECT/CT procedures. The study also outlines healthcare infrastructure and MI procedure volumes in the United States and EU-5 countries, including Germany, France, Italy, the United Kingdom, and Spain.

More than 36 million MI procedures are carried out, globally, and this number is increasing by 4%–6%, annually, driven by the rising number of patients with cancer, cardiac disease, and neurological ailments. Owing to the surging MI procedures, demand for the in-house production of radioisotopes using cyclotrons is rising. In addition, due to technology advancements and investments in R&D, new radiotracers have been developed, which has expanded the clinical application of MI equipment in neurology and oncology.

Table of Contents

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the Molecular Imaging (MI) Procedures Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Market Segmentation

Therapeutic Indications

Molecular Imaging Procedures Ecosystem—Present and Future

Key Highlights

Key Growth Metrics

Procedures Forecast

Procedures Forecast by Product Segment

COVID-19 Impact and Challenges Outlook, 2022

PET/CT Procedures by Clinical Application

Procedure Volume by Clinical Application

Procedure Volume by Geography

Key Trends—The Introduction of New Radiopharmaceuticals will Accelerate the Growth of PET/CT Imaging Procedures

Key Trends—The Next Big Opportunity for PET Scanning Lies in its Potential to Aid the Diagnosis of Alzheimer’s Disease

SPECT/CT Procedures by Clinical Application

Procedure Volume by Clinical Application

Procedure Volume by Geography

Technology is Set to Take Center Stage

Key Trends—Expansion of the Installed Base of Cyclotrons for the In-house Production of Radiotracers

Key Trends—Expansion of the Installed Base of Cyclotrons for the In-house Production of Radiotracers (continued)

Hospital Landscape and MI Equipment Infrastructure—United States

Hospital Landscape and MI Equipment Infrastructure—Germany

Hospital Landscape and MI Equipment Infrastructure—France

Hospital Landscape and MI Equipment Infrastructure—Italy

Hospital Landscape and MI Equipment Infrastructure—Spain

Hospital Landscape and MI Equipment Infrastructure—United Kingdom

Growth Opportunity 1—Increased Adoption of Cyclotrons for the In-house Production of Radionuclides

Growth Opportunity 1—Increased Adoption of Cyclotrons for the In-house Production of Radionuclides (continued)

Growth Opportunity 2—AI Platforms in MI for Improved Patient Care

Growth Opportunity 2—AI Platforms in MI for Improved Patient Care (continued)

Growth Opportunity 3—Favorable Reimbursement Policies to Encourage Molecular Imaging to Enter New Therapeutic Areas such as Neurology

Growth Opportunity 3—Favorable Reimbursement Policies to Encourage Molecular Imaging to Enter New Therapeutic Areas such as Neurology (continued)

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

This Frost & Sullivan research service presents an analysis of the global molecular imaging (MI) procedures market and an overview of the development of novel radiopharmaceuticals. It offers an in-depth analysis of current trends and a forecast for PET/CT and SPECT/CT procedures. The study also outlines healthcare infrastructure and MI procedure volumes in the United States and EU-5 countries, including Germany, France, Italy, the United Kingdom, and Spain. More than 36 million MI procedures are carried out, globally, and this number is increasing by 4%–6%, annually, driven by the rising number of patients with cancer, cardiac disease, and neurological ailments. Owing to the surging MI procedures, demand for the in-house production of radioisotopes using cyclotrons is rising. In addition, due to technology advancements and investments in R&D, new radiotracers have been developed, which has expanded the clinical application of MI equipment in neurology and oncology.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Vishnu Bhargav Yanamandra
Industries Healthcare
WIP Number PCB3-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9825-B1,9A06-B1,9566-B1,9570-B1,99CC-B1,99BE-B1,9614-B1